Medical/Pharmaceuticals

ASEAN accepts mutually recognized COVID-19 vaccination certificates

DENPASAR, Indonesia, May 17, 2022 /PRNewswire/ -- ASEAN Member States collectively recognize the COVID-19 vaccination certificate to be applied in Southeast Asia. Health Ministers of ASEAN countries endorsed the decision during the 15th ASEAN Health Ministers Meeting (15th AHMM) inNusa Dua, Bali, ...

2022-05-17 19:14 1937

New therapeutic option to reduce risk of cardiovascular deaths and repeated hospitalizations among adult heart failure patients approved in Singapore

* Over the course of the VICTORIA study, there was a 4.2% reduction in annualized absolute risk with VERQUVO™ (vericiguat) compared with placebo in reducing the risk of cardiovascular death or heart failure (HF) hospitalization in adults with symptomatic chronic HF and ejection fraction less th...

2022-05-17 16:32 1706

ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY

PARIS, May 17, 2022 /PRNewswire/ -- ABL Europe (ABL ), a pure play contract development and manufacturing organization (CDMO) specialized in development and manufacturing of virus for vaccine candidates, gene and cancer therapies and Odimma Therapeutics (Od...

2022-05-17 15:00 1995

CStone announces final PFS analysis of a registrational study of sugemalimab in patients with stage III NSCLC further demonstrates its robust efficacy and significant clinical benefits shown in interim analysis

* Sugemalimab is the world's first anti-PD-(L)1 monoclonal antibody to significantly improve progression-free survival (PFS) in patients with stage III non-small cell lung cancer (NSCLC) without disease progression following concurrent or sequential chemoradiotherapy * The National Medical Pr...

2022-05-17 08:02 2640

LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with Its Interoperable Precision Health Solutions

The Interoperable Precision Health Solutions improve access, flexibility, agility, and awareness, driving adoption anddelivering more cost-efficient, targeted healthcare utilization. SAN ANTONIO, May 16, 2022 /PRNewswire/ -- Based on a recent industry assessment of the precision health informati...

2022-05-16 22:00 2325

Ascletis (1672.HK) Included in MSCI China Small Cap Index

HANGZHOU and SHAOXING, China, May 16, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it will be included in the MSCI China Small Cap Index, effective after the market close onMay 31, 2022. Morgan Stanley Capital International (MSCI) is a leading provider o...

2022-05-16 20:17 3585

SOFWAVE™ TECHNOLOGY WINS MAJOR BEAUTY AWARDS -- 2022 ADDING TO THE 2021 ELLE AWARD

Cosmopolitan, NewBeauty, and SHAPE Name Sofwave™ Technology the Industry's Best SAN CLEMENTE, Calif., May 16, 2022 /PRNewswire/ -- Sofwave™ Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, is thrilled to announce it ...

2022-05-16 20:00 2075

Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China

-Distribution channels in place to streamline/facilitate patient access. -XPOVIO® will be available in 600 hospitals and 105 DTPs (across China includingBeijing, Shanghai, Guangdong, Jiangsu, Zhejiang, Henan, and Shandong). SHANGHAI and HONG KONG, May 16, 2022 /PRNewswire/ -- Antengene Corporatio...

2022-05-16 11:20 2600

Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system

- First EIB support for medtech investment in Israel - Financing to accelerate development of rapid testing system to improve infectious disease diagnosis and antibiotics stewardship - Automated phenotypic testing, revolutionizing infectious diseases diagnostics from sample to answer REHOVOT, I...

2022-05-16 10:00 2676

UMP Purchases Advanced Medical Imaging Equipment and Facilities

Further Extends its Services Area in Central CBD with New Centre Opening HONG KONG, May 16, 2022 /PRNewswire/ -- UMP Healthcare Holdings Limited ("UMP" or the "Group", SEHK: 722) is pleased to announce that it will rent the whole of 1st floor, 2nd floor, 3rd floor (plus a terrace) and 5th floor o...

2022-05-16 08:00 3120

Innovent Will Present Clinical Data of IBI110 (anti-LAG-3 monoclonal antibody) and Other Multiple Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, May 16, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-05-16 08:00 3125

Seegene reports first quarter 2022 financial results

* Q1 revenue up 10% QoQ to reach record quarterly high of KRW 451.5 billion * Foundation for sales expansion strengthened through '3 Ct' technology commercialization, Allplex™ RV Master Assay approval, increased PCR instrument sales * "Seegene to secure future growth by targeting syndromic t...

2022-05-13 19:00 2596

Antengene Announces XPOVIO® (selinexor) Data to be Presented at the Upcoming 2022 European Hematology Association Hybrid Congress

SHANGHAI and HONG KONG, May 13, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...

2022-05-13 18:00 2550

NEW GUIDELINES FOR COVID TESTING

A new ISO technical specification will improve testing procedures and contribute to a safer world. SHENZHEN, China, May 13, 2022 /PRNewswire/ -- The COVID pandemic first reared its head in 2019 and despite concerted efforts from authorities and the public, it's still with us. Dedicated stan...

2022-05-13 17:10 2021

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines

SHANGHAI and HONG KONG, May 13, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...

2022-05-13 08:30 2328

ECCMID 2022: Copan unveils its WISE approach to sample management

BRESCIA, Italy, May 12, 2022 /PRNewswire/ -- Copan took the chance of the first in-person ECCMID of the last two years to give a name to itsholistic approach to preanalytics. From sample collection to image analysis and data interpretation, meet Copan's WISE approach, which brings any sample to i...

2022-05-12 20:25 2035

INFOBAE.COM: Houston doctors and researchers that are making the biggest international impact according to the KOLs list - Most of them are women

SANTA BARBARA, Calif., May 12, 2022 /PRNewswire/ -- The work of Houston doctors and researchers is getting international attention. The most researched areas in Houston after COVID are Oncology, Cardiology, and Endocrinology. According to the KOLs list, the leading institutions are The University ...

2022-05-12 08:22 1438

DetectedX Launches Radiology Online Learning Platform to the U.S. Market at SBI

The Intelligent Interactive Educational Technology from DetectedX has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases SAVANNAH, Ga., May 11, 2022 /PRNewswire/ -- DetectedX announced today that it will launch its Radiology Online Learning Platform...

2022-05-11 20:00 2331

WORLD BRAIN DAY 2022 IS DEDICATED TO BRAIN HEALTH FOR ALL

LONDON, May 11, 2022 /PRNewswire/ -- On Friday, July 22, the World Federation of Neurology (WFN) is hosting the 9th Annual World Brain Day. WFN is pleased to announce that this year's theme isBrain Health for All. The all-encompassing theme aims to spark a universal effort that will share crucial...

2022-05-11 14:00 1778

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022

GAITHERSBURG, Md. and SUZHOU, China, May 11, 2022 /PRNewswire/ -- Sirnaomics Ltd.  ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will present the latest developments o...

2022-05-11 13:05 2135
1 ... 148149150151152153154 ... 383